344 related articles for article (PubMed ID: 28030619)
1. Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation.
Nguyen LD; Deschaght P; Merlin S; Loywick A; Audebert C; Van Daele S; Viscogliosi E; Vaneechoutte M; Delhaes L
PLoS One; 2016; 11(12):e0168860. PubMed ID: 28030619
[TBL] [Abstract][Full Text] [Related]
2. Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.
Botterel F; Angebault C; Cabaret O; Stressmann FA; Costa JM; Wallet F; Wallaert B; Bruce K; Delhaes L
Mycopathologia; 2018 Feb; 183(1):171-183. PubMed ID: 28766039
[TBL] [Abstract][Full Text] [Related]
3. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.
Fodor AA; Klem ER; Gilpin DF; Elborn JS; Boucher RC; Tunney MM; Wolfgang MC
PLoS One; 2012; 7(9):e45001. PubMed ID: 23049765
[TBL] [Abstract][Full Text] [Related]
4. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
[TBL] [Abstract][Full Text] [Related]
5. The metabolic footprint of the airway bacterial community in cystic fibrosis.
Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
[TBL] [Abstract][Full Text] [Related]
6. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience.
Stressmann FA; Rogers GB; van der Gast CJ; Marsh P; Vermeer LS; Carroll MP; Hoffman L; Daniels TW; Patel N; Forbes B; Bruce KD
Thorax; 2012 Oct; 67(10):867-73. PubMed ID: 22707521
[TBL] [Abstract][Full Text] [Related]
7. Reducing bias in bacterial community analysis of lower respiratory infections.
Rogers GB; Cuthbertson L; Hoffman LR; Wing PA; Pope C; Hooftman DA; Lilley AK; Oliver A; Carroll MP; Bruce KD; van der Gast CJ
ISME J; 2013 Apr; 7(4):697-706. PubMed ID: 23190732
[TBL] [Abstract][Full Text] [Related]
8. Decade-long bacterial community dynamics in cystic fibrosis airways.
Zhao J; Schloss PD; Kalikin LM; Carmody LA; Foster BK; Petrosino JF; Cavalcoli JD; VanDevanter DR; Murray S; Li JZ; Young VB; LiPuma JJ
Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5809-14. PubMed ID: 22451929
[TBL] [Abstract][Full Text] [Related]
9. Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention.
Cuthbertson L; Rogers GB; Walker AW; Oliver A; Green LE; Daniels TW; Carroll MP; Parkhill J; Bruce KD; van der Gast CJ
ISME J; 2016 May; 10(5):1081-91. PubMed ID: 26555248
[TBL] [Abstract][Full Text] [Related]
10. Lung microbiota across age and disease stage in cystic fibrosis.
Coburn B; Wang PW; Diaz Caballero J; Clark ST; Brahma V; Donaldson S; Zhang Y; Surendra A; Gong Y; Elizabeth Tullis D; Yau YC; Waters VJ; Hwang DM; Guttman DS
Sci Rep; 2015 May; 5():10241. PubMed ID: 25974282
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the bacterial microbiome in first-pass meconium using propidium monoazide (PMA) to exclude nonviable bacterial DNA.
Stinson LF; Keelan JA; Payne MS
Lett Appl Microbiol; 2019 May; 68(5):378-385. PubMed ID: 30674082
[TBL] [Abstract][Full Text] [Related]
12. Analysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear period.
Stokell JR; Gharaibeh RZ; Hamp TJ; Zapata MJ; Fodor AA; Steck TR
J Clin Microbiol; 2015 Jan; 53(1):237-47. PubMed ID: 25392361
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
Zemanick ET; Harris JK; Wagner BD; Robertson CE; Sagel SD; Stevens MJ; Accurso FJ; Laguna TA
PLoS One; 2013; 8(4):e62917. PubMed ID: 23646159
[TBL] [Abstract][Full Text] [Related]
14. Whole microbial community viability is not quantitatively reflected by propidium monoazide sequencing approach.
Wang Y; Yan Y; Thompson KN; Bae S; Accorsi EK; Zhang Y; Shen J; Vlamakis H; Hartmann EM; Huttenhower C
Microbiome; 2021 Jan; 9(1):17. PubMed ID: 33478576
[TBL] [Abstract][Full Text] [Related]
15. Respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis.
Soret P; Vandenborght LE; Francis F; Coron N; Enaud R; Avalos M; Schaeverbeke T; Berger P; Fayon M; Thiebaut R; Delhaes L;
Sci Rep; 2020 Feb; 10(1):3589. PubMed ID: 32108159
[TBL] [Abstract][Full Text] [Related]
16. Reducing Viability Bias in Analysis of Gut Microbiota in Preterm Infants at Risk of NEC and Sepsis.
Young GR; Smith DL; Embleton ND; Berrington JE; Schwalbe EC; Cummings SP; van der Gast CJ; Lanyon C
Front Cell Infect Microbiol; 2017; 7():237. PubMed ID: 28634574
[TBL] [Abstract][Full Text] [Related]
17. Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis.
Daniels TW; Rogers GB; Stressmann FA; van der Gast CJ; Bruce KD; Jones GR; Connett GJ; Legg JP; Carroll MP
J Cyst Fibros; 2013 Jan; 12(1):22-8. PubMed ID: 22717533
[TBL] [Abstract][Full Text] [Related]
18. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.
Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C
Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782
[TBL] [Abstract][Full Text] [Related]
19. The effects of inhaled aztreonam on the cystic fibrosis lung microbiome.
Heirali AA; Workentine ML; Acosta N; Poonja A; Storey DG; Somayaji R; Rabin HR; Whelan FJ; Surette MG; Parkins MD
Microbiome; 2017 May; 5(1):51. PubMed ID: 28476135
[TBL] [Abstract][Full Text] [Related]
20. Microbiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation.
Twomey KB; Alston M; An SQ; O'Connell OJ; McCarthy Y; Swarbreck D; Febrer M; Dow JM; Plant BJ; Ryan RP
PLoS One; 2013; 8(12):e82432. PubMed ID: 24358183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
